期刊
CLINICAL THERAPEUTICS
卷 39, 期 10, 页码 2088-2094出版社
ELSEVIER
DOI: 10.1016/j.clinthera.2017.08.014
关键词
diabetic foot; hyperbaric oxygen therapy; randomized clinical trials; meta-analysis
资金
- Natural Science Foundation of China [81300657, 81370925]
Purpose: The efficacy and safety profile of hyperbaric oxygen therapy (HBOT) in patients with diabetic foot ulcer have been controversial in recent years. Our meta-analysis was undertaken to evaluate the efficacy and safety profile of HBOT in patients with diabetic foot ulcer. Methods: We searched the PubMed, Cochrane Library, EMBASE, and Clinical Trials.gov databases for controlled trials. The efficacy end points included the incidence of healed ulcers, major amputations, minor amputations, and reduction in the ulcer wound area. The tolerability end point was the incidence of adverse events. Findings: Nine randomized clinical trials involving 526 patients met the inclusion criteria. No difference was found in the incidence of healed ulcers (risk ratio [RR] = 2.22; 95% CI, 0.87-5.62; P = 0.32; I-2 = 81%), minor amputations (RR = 0.95; 95% CI, 0.39-2.29; P = 0.91; I-2 = 74%), major amputations (RR = 0.47; 95% CI, 0.17-1.28; P = 0.14; I-2 = 61%), and adverse events (RR = 1.00; 95% CI, 0.64-1.56; P = 0.99; I-2 = 26%) between the HBOT and standard therapy (ST) groups. HBOT was associated with a greater reduction in the ulcer wound area versus ST (standard mean difference = 1.12; 95% CI, 0.20-2.04; P = 0.04; I-2 = 70%). (C) 2017 Elsevier HS Journals, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据